Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer

Background/Aims The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating meta-static pancreatic cancer (MPC). We aimed to evaluate the therapeutic outcomes and prognostic role of treatment-related peripheral neuropathy in patients with MPC treated with nab-P/Gem in c...

Descripció completa

Dades bibliogràfiques

Autors principals:	Min Su You, Ji Kon Ryu, Young Hoon Choi, Jin Ho Choi, Gunn Huh, Woo Hyun Paik, Sang Hyub Lee, Yong-Tae Kim
Format:	Artigo
Idioma:	Inglês
Publicat:	Gastroenterology Council for Gut and Liver 2018-11-01
Col·lecció:	Gut and Liver
Matèries:	pancreatic neoplasm metastasis chemotherapy gemcitabine nab-paclitaxel
Accés en línia:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl18220
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!